{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:43:02Z","timestamp":1789904582919,"version":"4.0.1"},"reference-count":144,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health of the United States","award":["NS108887"],"award-info":[{"award-number":["NS108887"]}]},{"name":"National Institutes of Health of the United States","award":["NS120617"],"award-info":[{"award-number":["NS120617"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Neuropathic pain is a chronic condition resulting from injury or dysfunction in the somatosensory nervous system, which leads to persistent pain and a significant impairment of quality of life. Research has highlighted the complex molecular mechanisms that underlie neuropathic pain and has begun to delineate the roles of microRNAs (miRNAs) in modulating pain pathways. miRNAs, which are small non-coding RNAs that regulate gene expression post-transcriptionally, have been shown to influence key cellular processes, including neuroinflammation, neuronal excitability, and synaptic plasticity. These processes contribute to the persistence of neuropathic pain, and miRNAs have emerged as critical regulators of pain behaviors by modulating signaling pathways that control pain sensitivity. miRNAs can influence neuropathic pain by targeting genes that encode protein kinases involved in pain signaling. This review focuses on miRNAs that have been demonstrated to modulate neuropathic pain behavior through their effects on protein kinases or their immediate upstream regulators. The relationship between miRNAs and neuropathic pain behaviors is characterized as either an upregulation or a downregulation of miRNA levels that leads to a reduction in neuropathic pain. In the case of miRNA upregulation resulting in an alleviation of neuropathic pain behaviors, protein kinases exhibit a positive correlation with neuropathic pain, whereas decreased protein kinase levels correlate with diminished neuropathic pain behaviors. The only exception is GRK2, which shows an inverse correlation with neuropathic pain. In the case of miRNA downregulation resulting in a reduction in neuropathic pain behaviors, protein kinases display mixed relationships to neuropathic pain, with some kinases exhibiting positive correlation, while others exhibit negative correlation. By exploring how protein kinases mediate miRNA modulation of neuropathic pain, valuable insight may be gained into the pathophysiology of neuropathic pain, offering potential therapeutic targets for developing more effective strategies for pain management.<\/jats:p>","DOI":"10.3390\/cells14080577","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T10:05:51Z","timestamp":1744365951000},"page":"577","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Protein Kinases as Mediators for miRNA Modulation of Neuropathic Pain"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8264-5326","authenticated-orcid":false,"given":"Leah","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Genetics, Center of Alcohol & Substance Use Studies, Rutgers University, Piscataway, NJ 08854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zala","family":"\u010cok","sequence":"additional","affiliation":[{"name":"Department of Genetics, Center of Alcohol & Substance Use Studies, Rutgers University, Piscataway, NJ 08854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-3951","authenticated-orcid":false,"given":"Lei","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Genetics, Center of Alcohol & Substance Use Studies, Rutgers University, Piscataway, NJ 08854, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Colloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A.H., Yarnitsky, D., Freeman, R., Truini, A., Attal, N., and Finnerup, N.B. (2017). Neuropathic pain. Nat. Rev. Dis. Primers, 3.","DOI":"10.1038\/nrdp.2017.2"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"The IASP classification of chronic pain for ICD-11: Chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"Pain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s44158-024-00212-z","article-title":"Understanding neuropathic pain: The role of neurophysiological tests in unveiling underlying mechanisms","volume":"4","author":"Leone","year":"2024","journal-title":"J. Anesth. Analg. Crit. Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.31083\/j.jin2305089","article-title":"The Complexity of Neuropathic Pain and Central Sensitization: Exploring Mechanisms and Therapeutic Prospects","volume":"23","author":"Ma","year":"2024","journal-title":"J. Integr. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lima Pess\u00f4a, B., Hauwanga, W.N., Thomas, A., Valentim, G., and McBenedict, B. (2024). A Comprehensive Narrative Review of Neuropathic Pain: From Pathophysiology to Surgical Treatment. Cureus, 16.","DOI":"10.7759\/cureus.58025"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: A systematic review of epidemiological studies","volume":"155","author":"Austin","year":"2014","journal-title":"Pain"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Cavalli, E., Mammana, S., Nicoletti, F., Bramanti, P., and Mazzon, E. (2019). The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int. J. Immunopathol. Pharmacol., 33.","DOI":"10.1177\/2058738419838383"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1474-4422(18)30071-1","article-title":"Diagnosis and assessment of neuropathic pain through questionnaires","volume":"17","author":"Attal","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-0044-1791770","article-title":"Pharmacologic and Nonpharmacologic Management of Neuropathic Pain","volume":"45","author":"Feldman","year":"2025","journal-title":"Semin. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: Evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: An overview of recent guidelines","volume":"122","author":"Dworkin","year":"2009","journal-title":"Am. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.pain.2013.06.004","article-title":"Interventional management of neuropathic pain: NeuPSIG recommendations","volume":"154","author":"Dworkin","year":"2013","journal-title":"Pain"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Andrejic, N., Bo\u017eovic, I., Moradi, H., Tataei, R., and Knezevic, N.N. (2025). Neuropathic pain management: A focused review of current treatments and novel data from main ongoing clinical trials. Expert. Opin. Investig. Drugs, Online ahead of print.","DOI":"10.1080\/13543784.2025.2473692"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sadegh, A.A., Gehr, N.L., and Finnerup, N.B. (2024). A systematic review and meta-analysis of randomized controlled head-to-head trials of recommended drugs for neuropathic pain. Pain. Rep., 9.","DOI":"10.1097\/PR9.0000000000001138"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Moisset, X. (2024). Neuropathic pain: Evidence based recommendations. Presse Med., 53.","DOI":"10.1016\/j.lpm.2024.104232"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/bs.irn.2024.10.002","article-title":"Molecular mechanisms of neuropathic pain","volume":"179","author":"Pacifico","year":"2024","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Rugnath, R., Orzechowicz, C., Newell, C., Carullo, V., and Rugnath, A. (2024). A Literature Review: The Mechanisms and Treatment of Neuropathic Pain-A Brief Discussion. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010204"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.31662\/jmaj.2023-0009","article-title":"Roles of MicroRNAs in Disease Biology","volume":"6","author":"Suzuki","year":"2023","journal-title":"JMA J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nlm.2011.04.004","article-title":"MicroRNA regulation of neural plasticity and memory","volume":"96","author":"Bredy","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kalpachidou, T., Kummer, K.K., and Kress, M. (2020). Non-coding RNAs in neuropathic pain. Neuronal Signal, 4.","DOI":"10.1042\/NS20190099"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1046\/j.0014-2956.2001.02473.x","article-title":"The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture","volume":"268","author":"Cohen","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)","volume":"40","author":"Ardito","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.tibs.2024.08.004","article-title":"The expanding landscape of canonical and non-canonical protein phosphorylation","volume":"49","author":"Houles","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2008.12.011","article-title":"MAP kinase and pain","volume":"60","author":"Ji","year":"2009","journal-title":"Brain Res. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Mai, L., Zhu, X., Huang, F., He, H., and Fan, W. (2020). p38 mitogen-activated protein kinase and pain. Life Sci., 256.","DOI":"10.1016\/j.lfs.2020.117885"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s13311-020-00881-y","article-title":"Interactions Among lncRNAs\/circRNAs, miRNAs, and mRNAs in Neuropathic Pain","volume":"17","author":"Song","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gada, Y., Pandey, A., Jadhav, N., Ajgaonkar, S., Mehta, D., and Nair, S. (2021). New Vistas in microRNA Regulatory Interactome in Neuropathic Pain. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.778014"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Jiang, M., Wang, Y., Wang, J., Feng, S., and Wang, X. (2022). The etiological roles of miRNAs, lncRNAs, and circRNAs in neuropathic pain: A narrative review. J. Clin. Lab. Anal., 36.","DOI":"10.1002\/jcla.24592"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Morchio, M., Sher, E., Collier, D.A., Lambert, D.W., and Boissonade, F.M. (2023). The Role of miRNAs in Neuropathic Pain. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030775"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zhao, Y.Y., Wu, Z.J., Zhu, L.J., Niu, T.X., Liu, B., and Li, J. (2023). Emerging roles of miRNAs in neuropathic pain: From new findings to novel mechanisms. Front. Mol. Neurosci., 16.","DOI":"10.3389\/fnmol.2023.1110975"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Sampath, K.K., Belcher, S., Hales, J., Thomson, O.P., Farrell, G., Gisselman, A.S., Katare, R., and Tumilty, S. (2023). The role of micro-RNAs in neuropathic pain-a scoping review. Pain. Rep., 8.","DOI":"10.1097\/PR9.0000000000001108"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Golmakani, H., Azimian, A., and Golmakani, E. (2024). Newly discovered functions of miRNAs in neuropathic pain: Transitioning from recent discoveries to innovative underlying mechanisms. Mol. Pain., 20.","DOI":"10.1177\/17448069231225845"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1742-2094-9-143","article-title":"MicroRNA-124 as a novel treatment for persistent hyperalgesia","volume":"9","author":"Willemen","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/jcp.29276","article-title":"Upregulation of miR-183 represses neuropathic pain through inhibiton of MAP3K4 in CCI rat models","volume":"235","author":"Huang","year":"2020","journal-title":"J. Cell Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13258-019-00881-z","article-title":"MiR-15a attenuates peripheral nerve injury-induced neuropathic pain by targeting AKT3 to regulate autophagy","volume":"42","author":"Cai","year":"2020","journal-title":"Genes. Genomics"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbrc.2019.07.061","article-title":"Effects of miR-150 on neuropathic pain process via targeting AKT3","volume":"517","author":"Cai","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"You, H., Zhang, L., Chen, Z., Liu, W., Wang, H., and He, H. (2019). MiR-20b-5p relieves neuropathic pain by targeting Akt3 in a chronic constriction injury rat model. Synapse, 73.","DOI":"10.1002\/syn.22125"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neures.2019.09.002","article-title":"miR-101 down-regulates mTOR expression and attenuates neuropathic pain in chronic constriction injury rat models","volume":"158","author":"Xie","year":"2020","journal-title":"Neurosci. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000455987","article-title":"MicroRNA-183 Suppresses Neuropathic Pain and Expression of AMPA Receptors by Targeting mTOR\/VEGF Signaling Pathway","volume":"41","author":"Xie","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"ref_45","first-page":"57","article-title":"MicroRNA-362-3p attenuates motor deficit following spinal cord injury via targeting paired box gene 2","volume":"18","author":"Hu","year":"2019","journal-title":"J. Integr. Neurosci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2016.12.047","article-title":"Overexpression of miR-206 ameliorates chronic constriction injury-induced neuropathic pain in rats via the MEK\/ERK pathway by targeting brain-derived neurotrophic factor","volume":"646","author":"Sun","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI81950","article-title":"CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5","volume":"126","author":"Jiang","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Xu, B., Cao, J., Zhang, J., Jia, S., Wu, S., Mo, K., Wei, G., Liang, L., Miao, X., and Bekker, A. (2017). Role of MicroRNA-143 in Nerve Injury-Induced Upregulation of Dnmt3a Expression in Primary Sensory Neurons. Front. Mol. Neurosci., 10.","DOI":"10.3389\/fnmol.2017.00350"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.biopha.2018.08.005","article-title":"Effects of miR-26a-5p on neuropathic pain development by targeting MAPK6 in in CCI rat models","volume":"107","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12974-018-1215-4","article-title":"Chronic constriction injury-induced microRNA-146a-5p alleviates neuropathic pain through suppression of IRAK1\/TRAF6 signaling pathway","volume":"15","author":"Wang","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1002\/jcp.29465","article-title":"Knockdown of Linc00052 alleviated spinal nerve ligation-triggered neuropathic pain through regulating miR-448 and JAK1","volume":"235","author":"Wang","year":"2020","journal-title":"J. Cell Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11064-014-1500-2","article-title":"Suppression of microRNA-155 attenuates neuropathic pain by regulating SOCS1 signalling pathway","volume":"40","author":"Tan","year":"2015","journal-title":"Neurochem. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12031-016-0748-1","article-title":"Inhibition of MicroRNA-221 Alleviates Neuropathic Pain Through Targeting Suppressor of Cytokine Signaling 1","volume":"59","author":"Xia","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1007\/s12035-020-01999-y","article-title":"Upregulation of miR-133a-3p in the Sciatic Nerve Contributes to Neuropathic Pain Development","volume":"57","author":"Chang","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4062\/biomolther.2018.073","article-title":"Inhibition of MicroRNA-15a\/16 Expression Alleviates Neuropathic Pain Development through Upregulation of G Protein-Coupled Receptor Kinase 2","volume":"27","author":"Li","year":"2019","journal-title":"Biomol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1084\/jem.20180800","article-title":"TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG","volume":"215","author":"Zhang","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3892\/ijmm.2020.4824","article-title":"miR-142-3p targets AC9 to regulate sciatic nerve injury-induced neuropathic pain by regulating the cAMP\/AMPK signalling pathway","volume":"47","author":"Li","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"89949","DOI":"10.18632\/oncotarget.21192","article-title":"Long non-coding RNA CCAT1 modulates neuropathic pain progression through sponging miR-155","volume":"8","author":"Dou","year":"2017","journal-title":"Oncotarget"},{"key":"ref_59","first-page":"14374","article-title":"MiR-155 modulates the progression of neuropathic pain through targeting SGK3","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1093\/emboj\/16.16.4973","article-title":"A human homolog of the yeast Ssk2\/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways","volume":"16","author":"Takekawa","year":"1997","journal-title":"EMBO J."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Nguyen, K., Tran, M.N., Rivera, A., Cheng, T., Windsor, G.O., Chabot, A.B., Cavanaugh, J.E., Collins-Burow, B.M., Lee, S.B., and Drewry, D.H. (2022). MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types. Front. Biosci., 27.","DOI":"10.31083\/j.fbl2705167"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12672-024-00961-x","article-title":"MAP3K4 kinase action and dual role in cancer","volume":"15","author":"Huang","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1101\/gad.888501","article-title":"MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines","volume":"15","author":"Tournier","year":"2001","journal-title":"Genes. Dev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"32662","DOI":"10.1074\/jbc.M304229200","article-title":"A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates","volume":"278","author":"Ho","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11435","DOI":"10.1016\/S0021-9258(18)82142-1","article-title":"Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2","volume":"268","author":"Zheng","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1074\/jbc.271.10.5361","article-title":"Molecular cloning of mitogen-activated protein\/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase","volume":"271","author":"Blank","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1074\/jbc.272.13.8288","article-title":"Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway","volume":"272","author":"Gerwins","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"34029","DOI":"10.1074\/jbc.274.48.34029","article-title":"The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo","volume":"274","author":"Xu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bbamcr.2006.10.005","article-title":"The MEK\/ERK cascade: From signaling specificity to diverse functions","volume":"1773","author":"Shaul","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Hu, Q., Bian, Q., Rong, D., Wang, L., Song, J., Huang, H.S., Zeng, J., Mei, J., and Wang, P.Y. (2023). JAK\/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1110765"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"49105","DOI":"10.1074\/jbc.M204934200","article-title":"Stimulus-specific requirements for MAP3 kinases in activating the JNK pathway","volume":"277","author":"Chen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2174\/1874312901206010220","article-title":"c-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases","volume":"6","author":"Guma","year":"2012","journal-title":"Open Rheumatol. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1089\/jir.2014.0081","article-title":"Transcriptional regulation of pattern recognition receptors by Jak\/STAT signaling, and the implications for disease pathogenesis","volume":"34","author":"Jenkins","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Thompson, H.J., and Lutsiv, T. (2023). Natural Products in Precision Oncology: Plant-Based Small Molecule Inhibitors of Protein Kinases for Cancer Chemoprevention. Nutrients, 15.","DOI":"10.3390\/nu15051192"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Guo, N., Wang, X., Xu, M., Bai, J., Yu, H., and Le, Z. (2024). PI3K\/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression. Pharmacol. Res., 206.","DOI":"10.1016\/j.phrs.2024.107300"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3390\/nu5062231","article-title":"The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses","volume":"5","author":"Soliman","year":"2013","journal-title":"Nutrients"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.devcel.2022.02.024","article-title":"The central moTOR of metabolism","volume":"57","author":"Simcox","year":"2022","journal-title":"Dev. Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"25227","DOI":"10.1074\/jbc.M114.554881","article-title":"Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IkappaB kinase alpha (IKKalpha)","volume":"289","author":"Dan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semcdb.2016.01.040","article-title":"The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex","volume":"52","author":"Tee","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_81","first-page":"1169","article-title":"Single serine on TSC2 exerts biased control over mTORC1 activation mediated by ERK1\/2 but not Akt","volume":"5","author":"Pan","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Cormerais, Y., Lapp, S.C., Kalafut, K.C., Cisse, M.Y., Shin, J., Stefadu, B., Personnaz, J., Schrotter, S., D\u2019Amore, A., and Martin, E.R. (2024). AKT-mediated phosphorylation of TSC2 controls stimulus- and tissue-specific mTORC1 signaling and organ growth. bioRxiv.","DOI":"10.1101\/2024.09.23.614519"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Polchi, A., Magini, A., Meo, D.D., Tancini, B., and Emiliani, C. (2018). mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051474"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Liao, W.T., Chiang, Y.J., Yang-Yen, H.F., Hsu, L.C., Chang, Z.F., and Yen, J.J.Y. (2023). CBAP regulates the function of Akt-associated TSC protein complexes to modulate mTORC1 signaling. J. Biol. Chem., 299.","DOI":"10.1016\/j.jbc.2023.105455"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Wang, H., Chi, L., Yu, F., Dai, H., Si, X., Gao, C., Wang, Z., Liu, L., Zheng, J., and Ke, Y. (2022). The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers. Bioorg Med. Chem., 70.","DOI":"10.1016\/j.bmc.2022.116922"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1947601911407328","article-title":"The ERK Cascade: Distinct Functions within Various Subcellular Organelles","volume":"2","author":"Wortzel","year":"2011","journal-title":"Genes. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: Structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/geno.1996.0350","article-title":"Genomic structure of the human PAX2 gene","volume":"35","author":"Sanyanusin","year":"1996","journal-title":"Genomics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/path.2689","article-title":"VHL and HIF signalling in renal cell carcinogenesis","volume":"221","author":"Baldewijns","year":"2010","journal-title":"J. Pathol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)00100-8","article-title":"Receptor tyrosine kinases: Specific outcomes from general signals","volume":"103","author":"Simon","year":"2000","journal-title":"Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1091\/mbc.E15-07-0527","article-title":"Regulatory roles of conserved phosphorylation sites in the activation T-loop of the MAP kinase ERK1","volume":"27","author":"Lai","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bcp.2010.06.020","article-title":"The interleukin-1 receptor-associated kinases: Critical regulators of innate immune signalling","volume":"80","author":"Flannery","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Guegan, J.P., Fremin, C., and Baffet, G. (2012). The MAPK MEK1\/2-ERK1\/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control. Int. J. Hepatol., 2012.","DOI":"10.1155\/2012\/328372"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1042\/BCJ20170097","article-title":"The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists","volume":"474","author":"Vollmer","year":"2017","journal-title":"Biochem. J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"13316","DOI":"10.1021\/acs.jmedchem.0c00884","article-title":"Myeloid Differentiation Primary Response Protein 88 (MyD88): The Central Hub of TLR\/IL-1R Signaling","volume":"63","author":"Chen","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Hsieh, C.H., Jian, C.Z., Lin, L.I., Low, G.S., Ou, P.Y., Hsu, C., and Ou, D.L. (2022). Potential Role of CXCL13\/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer. Cancers, 14.","DOI":"10.3390\/cancers14020294"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Wang, B., Wang, M., Ao, D., and Wei, X. (2022). CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer. Biochim. Biophys. Acta Rev. Cancer, 1877.","DOI":"10.1016\/j.bbcan.2022.188799"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"13603","DOI":"10.1074\/jbc.M110.181743","article-title":"Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity","volume":"286","author":"Chernoff","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Chen, C., Nelson, L.J., Avila, M.A., and Cubero, F.J. (2019). Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link. Cells, 8.","DOI":"10.3390\/cells8101172"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Hegazy, M., Elkady, M.A., Yehia, A.M., Elsakka, E.G.E., Abulsoud, A.I., Abdelmaksoud, N.M., Elshafei, A., Abdelghany, T.M., Elkhawaga, S.Y., and Ismail, A. (2023). The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance\u2014A focus on signaling pathways interplay. Pathol. Res. Pract., 246.","DOI":"10.1016\/j.prp.2023.154510"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1210394","article-title":"Integrating signals from RTKs to ERK\/MAPK","volume":"26","author":"McKay","year":"2007","journal-title":"Oncogene"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jcp.27053","article-title":"Regulation of human mitogen-activated protein kinase 15 (extracellular signal-regulated kinase 7\/8) and its functions: A recent update","volume":"234","author":"Lau","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1469-8137.2010.03502.x","article-title":"Hubs and bottlenecks in plant molecular signalling networks","volume":"188","author":"Dietz","year":"2010","journal-title":"New Phytol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Bogucka, K., Pompaiah, M., Marini, F., Binder, H., Harms, G., Kaulich, M., Klein, M., Michel, C., Radsak, M.P., and Rosigkeit, S. (2020). ERK3\/MAPK6 controls IL-8 production and chemotaxis. Elife, 9.","DOI":"10.7554\/eLife.52511"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1515\/revneuro-2014-0067","article-title":"Role of Toll-like receptor\/MYD88 signaling in neurodegenerative diseases","volume":"26","author":"Xiang","year":"2015","journal-title":"Rev. Neurosci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbamem.2006.09.019","article-title":"The G protein-coupled receptor kinase (GRK) interactome: Role of GRKs in GPCR regulation and signaling","volume":"1768","author":"Ribas","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Gurevich, V.V., and Gurevich, E.V. (2019). GPCR Signaling Regulation: The Role of GRKs and Arrestins. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00125"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2741\/4860","article-title":"Molecular insights into kinase mediated signaling pathways of chemokines and their cognate G protein coupled receptors","volume":"25","author":"Tripathi","year":"2020","journal-title":"Front. Biosci."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Tao, J., Jiang, C., Guo, P., Chen, H., Zhu, Z., Su, T., Zhou, W., Tai, Y., Han, C., and Ma, Y. (2023). A novel GRK2 inhibitor alleviates experimental arthritis through restraining Th17 cell differentiation. Biomed. Pharmacother., 157.","DOI":"10.1016\/j.biopha.2022.113997"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Tian, T., Wei, M., Guan, Y., Rao, L., Luo, T., Han, C., Wei, W., and Ma, Y. (2025). Paeoniflorin-6\u2032-O-benzene sulfonate inhibits keratinocyte proliferation by restoring GRK2-JAK1 colocalization in mouse model of psoriasis. Cell Signal, 131.","DOI":"10.1016\/j.cellsig.2025.111706"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Palikhe, S., Ohashi, W., Sakamoto, T., Hattori, K., Kawakami, M., Andoh, T., Yamazaki, H., and Hattori, Y. (2019). Regulatory Role of GRK2 in the TLR Signaling-Mediated iNOS Induction Pathway in Microglial Cells. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00059"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.cr.7290257","article-title":"Activation and signaling of the p38 MAP kinase pathway","volume":"15","author":"Zarubin","year":"2005","journal-title":"Cell Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","article-title":"ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions","volume":"68","author":"Roux","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.3892\/mmr.2017.7384","article-title":"Downregulated SOCS1 expression activates the JAK1\/STAT1 pathway and promotes polarization of macrophages into M1 type","volume":"16","author":"Liang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1038\/sj.onc.1203925","article-title":"Janus kinases: Components of multiple signaling pathways","volume":"19","author":"Rane","year":"2000","journal-title":"Oncogene"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Bousoik, E., and Montazeri Aliabadi, H. (2018). \u201cDo We Know Jack\u201d About JAK? A Closer Look at JAK\/STAT Signaling Pathway. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00287"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/glia.21094","article-title":"Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFkappaB signaling, MAPK, and Jak1\/Stat1 pathways","volume":"59","author":"Gorina","year":"2011","journal-title":"Glia"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41467-018-04013-1","article-title":"The molecular basis of JAK\/STAT inhibition by SOCS1","volume":"9","author":"Liau","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/cbin.10915","article-title":"Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism","volume":"42","author":"Ke","year":"2018","journal-title":"Cell Biol. Int."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.gde.2004.11.002","article-title":"TSC1-2 tumour suppressor and regulation of mTOR signalling: Linking cell growth and proliferation?","volume":"15","author":"Findlay","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Chen, W., Pan, Y., Wang, S., Liu, Y., Chen, G., Zhou, L., Ni, W., Wang, A., and Lu, Y. (2017). Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells. BMC Cancer, 17.","DOI":"10.1186\/s12885-016-3038-y"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"27097","DOI":"10.18632\/oncotarget.4553","article-title":"AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, and TSC1\/TSC2","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Sharma, A., and Mehan, S. (2021). Targeting PI3K-AKT\/mTOR signaling in the prevention of autism. Neurochem. Int., 147.","DOI":"10.1016\/j.neuint.2021.105067"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"re17","DOI":"10.1126\/stke.2001.108.re17","article-title":"Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms","volume":"2001","author":"Lang","year":"2001","journal-title":"Sci. STKE"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bbrc.2005.03.159","article-title":"The serine\/threonine kinases SGK1, 3 and PKB stimulate the amino acid transporter ASCT2","volume":"331","author":"Palmada","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ceb.2009.10.007","article-title":"mTOR and cancer: Many loops in one pathway","volume":"22","author":"Efeyan","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.15252\/embj.201693929","article-title":"The hVps34-SGK3 pathway alleviates sustained PI3K\/Akt inhibition by stimulating mTORC1 and tumour growth","volume":"35","author":"Bago","year":"2016","journal-title":"EMBO J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/0470869976.ch9","article-title":"The mTOR\/S6K signalling pathway: The role of the TSC1\/2 tumour suppressor complex and the proto-oncogene Rheb","volume":"262","author":"Nobukini","year":"2004","journal-title":"Novartis Found. Symp."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1073\/pnas.0602282103","article-title":"TSC1\/TSC2 and Rheb have different effects on TORC1 and TORC2 activity","volume":"103","author":"Yang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"8778","DOI":"10.1128\/MCB.24.19.8778-8789.2004","article-title":"Protein phosphatase 2A negatively regulates insulin\u2019s metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes","volume":"24","author":"Ugi","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"19011","DOI":"10.1073\/pnas.0706696104","article-title":"Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner","volume":"104","author":"Andrabi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"C429","DOI":"10.1152\/ajpcell.00146.2020","article-title":"Akt scaffold proteins: The key to controlling specificity of Akt signaling","volume":"321","author":"Bao","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-6563-2_1","article-title":"miRNA Targeting Drugs: The Next Blockbusters?","volume":"1517","author":"Schmidt","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_140","first-page":"114","article-title":"How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market","volume":"30","author":"Bonneau","year":"2019","journal-title":"Ejifcc"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41392-024-02035-4","article-title":"Nucleic acid drugs: Recent progress and future perspectives","volume":"9","author":"Sun","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jare.2020.08.012","article-title":"Therapeutic advances of miRNAs: A preclinical and clinical update","volume":"28","author":"Chakraborty","year":"2021","journal-title":"J. Adv. Res."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Holjencin, C., and Jakymiw, A. (2022). MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention. Cells, 11.","DOI":"10.3390\/cells11152332"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","article-title":"MicroRNA: Trends in clinical trials of cancer diagnosis and therapy strategies","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/8\/577\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:12:59Z","timestamp":1760029979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/8\/577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":144,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["cells14080577"],"URL":"https:\/\/doi.org\/10.3390\/cells14080577","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]}}}